213 related articles for article (PubMed ID: 18425271)
1. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.
Araújo FR; Costa CM; Ramos CA; Farias TA; Souza II; Melo ES; Elisei C; Rosinha GM; Soares CO; Fragoso SP; Fonseca AH
Mem Inst Oswaldo Cruz; 2008 Mar; 103(2):186-90. PubMed ID: 18425271
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
[TBL] [Abstract][Full Text] [Related]
3. Association and evidence for linked recognition of type IV secretion system proteins VirB9-1, VirB9-2, and VirB10 in Anaplasma marginale.
Morse K; Norimine J; Palmer GH; Sutten EL; Baszler TV; Brown WC
Infect Immun; 2012 Jan; 80(1):215-27. PubMed ID: 22038917
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
Zhao L; Mahony D; Cavallaro AS; Zhang B; Zhang J; Deringer JR; Zhao CX; Brown WC; Yu C; Mitter N; Middelberg AP
PLoS One; 2016; 11(4):e0154295. PubMed ID: 27115492
[TBL] [Abstract][Full Text] [Related]
5. A partially purified outer membrane protein VirB9-1 for low-cost nanovaccines against Anaplasma marginale.
Zhao L; Cavallaro AS; Wibowo D; Zhang B; Zhang J; Mitter N; Yu C; Zhao CX; Middelberg AP
Vaccine; 2017 Jan; 35(1):77-83. PubMed ID: 27890399
[TBL] [Abstract][Full Text] [Related]
6. A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.
Sarli M; Novoa MB; Mazzucco MN; Signorini ML; Echaide IE; de Echaide ST; Primo ME
PLoS One; 2020; 15(2):e0229301. PubMed ID: 32084216
[TBL] [Abstract][Full Text] [Related]
7. Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.
Ducken DR; Brown WC; Alperin DC; Brayton KA; Reif KE; Turse JE; Palmer GH; Noh SM
PLoS One; 2015; 10(6):e0129309. PubMed ID: 26079491
[TBL] [Abstract][Full Text] [Related]
8. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
[TBL] [Abstract][Full Text] [Related]
9. Breadth of the CD4+ T cell response to Anaplasma marginale VirB9-1, VirB9-2 and VirB10 and MHC class II DR and DQ restriction elements.
Morse K; Norimine J; Hope JC; Brown WC
Immunogenetics; 2012 Jul; 64(7):507-23. PubMed ID: 22361828
[TBL] [Abstract][Full Text] [Related]
10. Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.
Kenneil R; Shkap V; Leibovich B; Zweygarth E; Pfister K; Ribeiro MF; Passos LM
Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():97-104. PubMed ID: 24589108
[TBL] [Abstract][Full Text] [Related]
11. Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale.
Abbott JR; Palmer GH; Kegerreis KA; Hetrick PF; Howard CJ; Hope JC; Brown WC
J Immunol; 2005 Jun; 174(11):6702-15. PubMed ID: 15905510
[TBL] [Abstract][Full Text] [Related]
12. Identification of IgG2-specific antigens in Mexican Anaplasma marginale strains.
Barigye R; García-Ortiz MA; Rojas Ramírez EE; Rodríguez SD
Ann N Y Acad Sci; 2004 Oct; 1026():84-94. PubMed ID: 15604474
[TBL] [Abstract][Full Text] [Related]
13. VirB10 vaccination for protection against Anaplasma phagocytophilum.
Crosby FL; Lundgren AM; Hoffman C; Pascual DW; Barbet AF
BMC Microbiol; 2018 Dec; 18(1):217. PubMed ID: 30563470
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.
Lopez JE; Siems WF; Palmer GH; Brayton KA; McGuire TC; Norimine J; Brown WC
Infect Immun; 2005 Dec; 73(12):8109-18. PubMed ID: 16299305
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.
de la Fuente J; Kocan KM; Garcia-Garcia JC; Blouin EF; Claypool PL; Saliki JT
Vet Microbiol; 2002 Oct; 89(2-3):239-251. PubMed ID: 12243900
[TBL] [Abstract][Full Text] [Related]
16. Cloning, sequencing and antigenic characterization of rVirB9 of Anaplasma marginale isolated from Paraná State, Brazil.
Vidotto MC; Venâncio EJ; Vidotto O
Genet Mol Res; 2008; 7(2):460-6. PubMed ID: 18561379
[TBL] [Abstract][Full Text] [Related]
17. CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge.
Brown WC; Shkap V; Zhu D; McGuire TC; Tuo W; McElwain TF; Palmer GH
Infect Immun; 1998 Nov; 66(11):5406-13. PubMed ID: 9784551
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.
Brown WC; McGuire TC; Mwangi W; Kegerreis KA; Macmillan H; Lewin HA; Palmer GH
Infect Immun; 2002 Oct; 70(10):5521-32. PubMed ID: 12228278
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-Based Delivery of Anaplasma marginale Membrane Proteins; VirB9-1 and VirB10 Produced in the Pichia pastoris Expression System.
Zhang B; Cavallaro AS; Mody KT; Zhang J; Deringer JR; Brown WC; Mahony TJ; Yu C; Mitter N
Nanomaterials (Basel); 2016 Nov; 6(11):. PubMed ID: 28335329
[TBL] [Abstract][Full Text] [Related]
20. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation.
Lopez JE; Beare PA; Heinzen RA; Norimine J; Lahmers KK; Palmer GH; Brown WC
J Immunol Methods; 2008 Mar; 332(1-2):129-41. PubMed ID: 18243240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
